Literature DB >> 12107680

C-reactive protein and mortality in patients with acute aortic disease.

Martin Schillinger1, Hans Domanovits, Keywan Bayegan, Thomas Hölzenbein, Martin Grabenwöger, Jana Thoenissen, Martin Röggla, Marcus Müllner.   

Abstract

OBJECTIVE: The association of acute-phase reaction and outcome of patients with acute vascular diseases is controversial. The prognostic value of admission C-reactive protein (CRP) in patients with acute aortic aneurysm or dissection has not yet been investigated. DESIGN AND
SETTING: Cohort study including 255 consecutive patients from an aneurysm registry with symptomatic thoracic or abdominal aortic aneurysm and/or dissection in an emergency department of a tertiary care university hospital. PATIENTS: Patients were included who had symptoms of aortic disease admitted between 1 January 1992 and 31 November 1998 and were followed up until 31 December 1999 for survival. MEASUREMENTS: Admission CRP (mg/dl) levels were categorized in quartiles: quartile 1, less than 0.5; quartile 2, 0.50-1.30; quartile 3, 1.31-6.30; quartile 4, higher than 6.30. Each group contained about 60 patients.
RESULTS: Cumulative mortality 1, 3, and 6 months after presentation was 32%, 37%, and 40%, respectively. Increased CRP levels were independently associated with mortality, adjusted for age, sex, hemodynamic shock, mechanical ventilation, coronary artery disease, aortic rupture, hemoglobin, diabetes, and treatment strategy (surgery vs. conservative). Hazard ratios in patients with CRP levels in quartiles 2-4 compared to quartile 1 were 0.7, 1.8, and 2.6, respectively.
CONCLUSIONS: Elevated admission CRP values in patients with symptomatic aortic aneurysm/dissection were independently associated with poor prognosis. CRP levels higher than 6.3 mg/dl indicate a high risk for short-term mortality.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12107680     DOI: 10.1007/s00134-002-1299-1

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  29 in total

1.  Are the recommendations to use perioperative beta-blocker therapy in patients undergoing noncardiac surgery based on reliable evidence?

Authors:  P J Devereaux; Salim Yusuf; Homer Yang; Peter T-L Choi; Gordon H Guyatt
Journal:  CMAJ       Date:  2004-08-03       Impact factor: 8.262

Review 2.  Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk.

Authors:  P J Devereaux; Lee Goldman; Deborah J Cook; Ken Gilbert; Kate Leslie; Gordon H Guyatt
Journal:  CMAJ       Date:  2005-09-13       Impact factor: 8.262

Review 3.  How strong is the evidence for the use of perioperative beta blockers in non-cardiac surgery? Systematic review and meta-analysis of randomised controlled trials.

Authors:  P J Devereaux; W Scott Beattie; Peter T-L Choi; Neal H Badner; Gordon H Guyatt; Juan C Villar; Claudio S Cinà; Kate Leslie; Michael J Jacka; Victor M Montori; Mohit Bhandari; Alvaro Avezum; Alexandre B Cavalcanti; Julian W Giles; Thomas Schricker; Homer Yang; Carl-Johan Jakobsen; Salim Yusuf
Journal:  BMJ       Date:  2005-07-04

4.  Plasma concentrations of D-dimer predict mortality in acute type A aortic dissection.

Authors:  T Weber; M Rammer; J Auer; E Maurer; G Aspöck; B Eber
Journal:  Heart       Date:  2006-06       Impact factor: 5.994

5.  Predictive value of high sensitivity C-reactive protein in the diagnosis and outcomes of acute aortic syndromes.

Authors:  Soufian T AlMahameed; Gian M Novaro; Craig R Asher; Penny L Hougthaling; Rodrigo M Lago; Deepak L Bhatt; Amjad T AlMahameed; Eric J Topol
Journal:  Heart Asia       Date:  2010-01-01

6.  Preoperative Predictors of Long-Term Mortality after Elective Endovascular Aneurysm Repair for Abdominal Aortic Aneurysm.

Authors:  Saya Nagai; Toshifumi Kudo; Yoshinori Inoue; Miho Akaza; Tetsuo Sasano; Yuki Sumi
Journal:  Ann Vasc Dis       Date:  2016-03-02

Review 7.  Management of acute aortic syndrome.

Authors:  Rachel E Clough; Christoph A Nienaber
Journal:  Nat Rev Cardiol       Date:  2014-12-16       Impact factor: 32.419

Review 8.  Can Specialized Pro-resolving Mediators Deliver Benefit Originally Expected from Fish Oil?

Authors:  Martin D Rosenthal; Jayshil Patel; Kyle Staton; Robert G Martindale; Frederick A Moore; Gilbert R Upchurch
Journal:  Curr Gastroenterol Rep       Date:  2018-08-04

9.  Neutrophil-lymphocyte ratio may predict in-hospital mortality in patients with acute type A aortic dissection.

Authors:  S Karakoyun; M O Gürsoy; T Akgün; L Öcal; M Kalçık; M Yesin; E Erdoğan; S Külahçıoğlu; R B Bakal; C Köksal; M Yıldız; M Özkan
Journal:  Herz       Date:  2014-07-26       Impact factor: 1.443

Review 10.  Evidence for C-reactive protein's role in (CRP) vascular disease: atherothrombosis, immuno-regulation and CRP.

Authors:  Sean P Mazer; LeRoy E Rabbani
Journal:  J Thromb Thrombolysis       Date:  2004-04       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.